Cargando…

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction

INTRODUCTION: The Siewert classification has been used to plan treatment for tumours of the gastro-oesophageal junction since its proposal in the 1980s. The purpose of this study was to assess its continued relevance by evaluating whether there were differences in the biology and clinical characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curtis, Nathan J, Noble, Fergus, Bailey, Ian S, Kelly, Jamie J, Byrne, James P, Underwood, Timothy J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263256/ https://www.ncbi.nlm.nih.gov/pubmed/24243140 http://dx.doi.org/10.1002/jso.23484

Ejemplares similares

Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival
por: Kauppila, Joonas H., et al.
Publicado: (2017)

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction
por: Li, Minmin, et al.
Publicado: (2014)

The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas
por: Dermanis, Alexander A., et al.
Publicado: (2023)

Combined Therapy of Locally Advanced Oesophageal and Gastro–Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors
por: Vošmik, Milan, et al.
Publicado: (2021)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives
por: Bîrlă, Rodica, et al.
Publicado: (2023)

Carcinoma of gastro-oesophageal junction in a pregnant woman
por: Kozak, Katarzyna, et al.
Publicado: (2018)

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
por: Zhao, Qun, et al.
Publicado: (2015)

Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: Erratum
Publicado: (2017)

Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
por: Propper, David, et al.
Publicado: (2016)

Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
por: Griffiths, Ewen A, et al.
Publicado: (2006)

Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction
por: Grillo, Federica, et al.
Publicado: (2020)

The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients
por: Goto, Hironobu, et al.
Publicado: (2014)

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
por: Noble, Fergus, et al.
Publicado: (2016)

Role and new perspectives of transforming growth factor-α (TGF- α) in adenocarcinoma of the gastro-oesophageal junction
por: D'Errico, A, et al.
Publicado: (2000)

Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours
por: Thomaschewski, Michael, et al.
Publicado: (2018)

Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro‐oesophageal junction
por: Christensen, J. F., et al.
Publicado: (2018)

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
por: Moureau-Zabotto, Laurence, et al.
Publicado: (2015)

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
por: Wainberg, Z A, et al.
Publicado: (2011)

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009)

Gastro-Œsophageal Intussusception
Publicado: (1935)

Adenocarcinoma of oesophagus involving gastro-oesophageal junction following mini-gastric bypass/ one anastomosis gastric bypass
por: Aggarwal, Sandeep, et al.
Publicado: (2020)

Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma
por: Zeng, Hanqing, et al.
Publicado: (2022)

KCNQ potassium channels modulate Wnt activity in gastro-oesophageal adenocarcinomas
por: Shorthouse, David, et al.
Publicado: (2023)

Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
por: Villanueva, Luis, et al.
Publicado: (2021)

Snoring induced reflux (SnoR) and a carcinoma in the gastro-oesophageal junction
por: Loske, Gunnar
Publicado: (2022)

EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus
por: Birkman, Eva-Maria, et al.
Publicado: (2016)

Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma
por: Manousopoulou, Antigoni, et al.
Publicado: (2018)

A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma
por: Mirza, A., et al.
Publicado: (2013)

Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction
por: Sugano, Kentaro, et al.
Publicado: (2022)

Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction
por: Yin, Qifan, et al.
Publicado: (2019)

Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort
por: Urabe, Masayuki, et al.
Publicado: (2018)

Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma()
por: Woolston, Caroline M., et al.
Publicado: (2013)

Gastro-oesophageal reflux disease and eosinophilic oesophagitis: What is the relationship?
por: Wong, Stephanie, et al.
Publicado: (2018)

Sensory Phenotype of the Oesophageal Mucosa in Gastro-Oesophageal Reflux Disease
por: Ustaoglu, Ahsen, et al.
Publicado: (2023)

Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
por: Cabeza-Segura, Manuel, et al.
Publicado: (2022)

Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
por: Pinto, C, et al.
Publicado: (2009)

Serum HER 2 Extracellular Domain Level Is Correlated with Tissue HER 2 Status in Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma
por: Dai, Shu-Qin, et al.
Publicado: (2013)

Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction
por: Xu, Jinming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1atupt8q4j4vajauc2od55gdrh